Main > ONCOLOGY (**) > Prostate Cancer MET HS > DE. B. Oral ARi+Docetaxel

---

DE. B. Oral ARi+Docetaxel's subsections
(*) USA Approval Date: 2022. 08.08
Company
Generic Name
RTM
RTM Web-Site
USA Patent Numbers

DE. B. Oral ARi+Docetaxel's products
This section has no products